The Missing Monitor: ASP and ChemDAQ Team Up

ASP and ChemDAQ partner to protect sterile processing staff from chemical sterilant exposure risks

2 Jun 2026

Nobody was watching the air. Sterilization equipment in hospital reprocessing departments has grown increasingly sophisticated, but continuous monitoring for hazardous sterilant gases has lagged well behind. That gap is now the target.

Advanced Sterilization Products and ChemDAQ announced a strategic partnership in April 2026, pairing ASP's widely deployed low-temperature STERRAD platform with ChemDAQ's real-time hazardous gas detection systems. For staff working regularly near hydrogen peroxide vapor and similar chemical sterilants, the implications are immediate. Exposure risks that once went untracked in real time will now have a dedicated monitoring layer built into the same operational framework as the sterilization technology itself.

Regulatory pressure is adding urgency. AAMI ST58, the key standard governing sterilant exposure in sterile processing environments, is increasingly referenced by healthcare regulators worldwide as exposure benchmarks tighten. Updated MDR obligations across the UK and EU, alongside revised GMP Annex 1 requirements, are raising contamination control standards in hospital reprocessing. ASP's STERRAD systems already operate in facilities across both regions, making ChemDAQ's monitoring infrastructure directly applicable to European teams facing these demands.

Together, the companies plan certified education programs, industry events, and thought-leadership initiatives to help sterile processing departments meet current and evolving compliance requirements. "Partnering with ChemDAQ reinforces our commitment to providing not just technology, but confidence," said Chad Rohrer, Group President, Fortive Infection Prevention Group.

Rising surgical volumes and stricter infection prevention expectations are pushing reprocessing demand higher at the same time. For hospital procurement teams and decontamination managers, this partnership marks a clear shift in how the industry frames the challenge: sterilization efficacy and environmental monitoring are no longer separate concerns. Treating them as a unified compliance problem is fast becoming the standard.